Man Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-62,900
Closed -$342K 2339
2024
Q4
$342K Buy
+62,900
New +$385K ﹤0.01% 1761
2024
Q3
Sell
-25,903
Closed -$281K 2175
2024
Q2
$281K Buy
+25,903
New +$332K ﹤0.01% 1802
2023
Q3
Sell
-80,661
Closed -$3.79M 2119
2023
Q2
$3.79M Buy
+80,661
New +$4.01M 0.01% 979
2023
Q1
Hold
0
926
2022
Q4
Sell
-9,053
Closed -$355K 2181
2022
Q3
$355K Buy
+9,053
New +$350K ﹤0.01% 1617
2022
Q2
Sell
-79,208
Closed -$2.65M 960
2022
Q1
$2.62M Buy
+79,208
New +$2.98M 0.01% 1137
2021
Q4
Sell
-4,603
Closed -$204K 2082
2021
Q3
$204K Buy
4,603
+1,095
+31% +$50.2K ﹤0.01% 1756
2021
Q2
$200K Sell
3,508
-11,710
-77% -$828K ﹤0.01% 1805
2021
Q1
$1.14M Sell
15,218
-33,714
-69% -$2.76M 0.01% 1259
2020
Q4
$4.23M Sell
48,932
-79,555
-62% -$5.86M 0.02% 902
2020
Q3
$7.85M Buy
128,487
+64,594
+101% +$3.27M 0.03% 582
2020
Q2
$2.66M Buy
63,893
+26,577
+71% +$965K 0.01% 946
2020
Q1
$1.07M Buy
+37,316
New +$2.16M 0.01% 1099
2019
Q4
Sell
-16,279
Closed -$2.28M 1897
2019
Q3
$2.28M Buy
16,279
+14,111
+651% +$2.36M 0.01% 1202
2019
Q2
$397K Sell
2,168
-11,047
-84% -$1.88M ﹤0.01% 1710
2019
Q1
$2.1M Buy
+13,215
New +$1.91M 0.01% 1315
2018
Q4
Sell
-15,452
Closed -$2.18M 2090
2018
Q3
$2.18M Buy
15,452
+10,848
+236% +$1.67M 0.01% 1388
2018
Q2
$721K Buy
4,604
+3,205
+229% +$503K ﹤0.01% 1702
2018
Q1
$225K Buy
+1,399
New +$238K ﹤0.01% 1902

Other funds holding SAGE